The Future of SARS-CoV-2 Vaccination Given the parade of SARS-CoV-2 variants, their increasing transmissibility, and concern about antigenic changes affecting vaccine protection, we need long-term ...
No takes yet. Share an insight, caveat, or question.
Arnold S. Monto (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: